Last reviewed · How we verify
GoodFOR Pain
GoodFOR Pain is an investigational analgesic agent designed to reduce pain signaling through modulation of pain pathways.
GoodFOR Pain is an investigational analgesic agent designed to reduce pain signaling through modulation of pain pathways. Used for Pain (indication not further specified in available data).
At a glance
| Generic name | GoodFOR Pain |
|---|---|
| Sponsor | Apothyx, Co. |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | Phase 3 |
Mechanism of action
Without disclosed mechanism details, GoodFOR Pain appears to be a pain management therapeutic in Phase 3 development by Apothyx, Co. The specific molecular target and mechanism of action have not been publicly disclosed in standard pharmaceutical databases.
Approved indications
- Pain (indication not further specified in available data)
Common side effects
Key clinical trials
- Topical CBD for Musculoskeletal Pain (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |